Puxitatug (INT-016) is a monoclonal antibody targeting VTCN1/B7-H4. Puxitatug can be used to synthesize antibody-drug conjugates (ADCs), such as Puxitatug samrotecan (HY-171689), which can be applied to various solid tumors. Puxitatug can also be used for researching adjuvant therapies for gastric cancer[1][2].
Molecular Weight:
(145 kDa)
Purity:
99.00
CAS Number:
[2760250-47-1]
Target:
CD276/B7-H3
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted